emtricitabine / tenofovir 200/300 mg

DRUG2 trials

Sponsors

Oswaldo Cruz Foundation

Conditions

HIVHIV, Prevention

Phase 4

Implementation of PrEP to HIV in Brazilian Transgender Women

Oswaldo Cruz FoundationHIV, Prevention

Start: 2017-07-10End: 2020-07-31Target: 120Updated: 2018-07-31

Unknown Phase

Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.

Oswaldo Cruz FoundationHIV

Start: 2014-06-30End: 2016-04-30Target: 400Updated: 2015-10-12

Related Papers

Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions

Clinical Pharmacokinetics2023-06-016 citations

Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug–drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis

Journal of Antimicrobial Chemotherapy2022-07-119 citations

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study

PLoS ONE2019-08-2060 citations

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

2018-02-18141 citations